Centene, Molina Hit Rough Patch With Exchange Biz, But See Positives Ahead

By Amy Lotven / February 18, 2021 at 6:24 PM
Centene and Molina had some rough patches with their exchange products in recent months, but officials from both companies said they are positive about the long-term prospects of their companies in their recent fourth quarter earnings calls and are pleased with the initial steps by the Biden administration to protect and expand coverage. In November, Molina told investors that its bronze-tier exchange plans had underperformed for the third quarter, largely because the insurer had not been able control utilization and...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.